Bob Cowart's Blog: Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach - Penn Medicine

Friday, April 16, 2021

Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach - Penn Medicine

This is not Breaking news but it is just coming to my attention now and is very exciting news.

https://www.pennmedicine.org/news/news-releases/2019/november/results-first-us-trial-crispr-edited-immune-cells-cancer-patients-safety-of-approach

No comments:

Post a Comment

Please be constructive in your comments.

Subscribe to: Post Comments (Atom)